/ /

  • linkedin
  • Increase Font
  • Sharebar

    AOA addresses concerns of optometric profession

    Seattle—The American Optometric Association (AOA) Board of Trustees addressed some of the concerns of optometrists across the U.S.—unilateral pricing policies (UPP), the Affordable Care Act (ACA), scope of practice, and more—during a session at Optometry’s Meeting.    

    During the session—which was approved for CE credit for the first time—the board briefed the audience on a number of hot topics and responded to questions from attendees.


    UPP uncertainty

    1-800-CONTACTS is waging a legislative war against UPP in 14 states and has already won in its home state of Utah—for the time being, at least.

    “The AOA got mobilized, worked with our state government relations center (SGRC) and with those state associations, encouraging them to fight the legislation and worked on strategies on how to do that,” says AOA Trustee Samuel Pierce, OD.

    Related: AOA fights back against 1-800-CONTACTS-backed state legislation

    Johnson & Johnson Vision Care and Alcon filed an injunction against the anti-UPP law in Utah, which was upheld, but then the 10th Circuit Court of Appeals overturned the injunction, allowing the bill to go forward.

    “However, the hearings on that injunction have been fast tracked. There should be a decision pretty soon—within the first week or two of July—regarding whether or not that bill will be challenged,” says Dr. Pierce.

    Next: Converting students to members

    Colleen E. McCarthy
    Colleen McCarthy is a freelance writer based in the Cleveland area and a former editor of Optometry Times. She is a 2010 graduate of the ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V